19 research outputs found
The Canadian Natural Health Products (NHP) Regulations: Industry Compliance Motivations
This qualitative study explores corporations' motivations to comply with new natural health products (NHP) Regulations in Canada. Interviews were conducted with representatives from 20 Canadian NHP companies. Findings show that the rationale for compliance differs for large compared to small and medium-sized enterprises (SMEs). Large firms are motivated to comply with the regulations because of the deterrent fear of negative media coverage, social motivations, ability to comply and maintaining a competitive market advantage. In contrast, SMEs are motivated to comply due to the deterrent fear of legal prosecution and a sense of duty
Advance Access Publication
This qualitative study explores corporations' motivations to comply with new natural health products (NHP) Regulations in Canada. Interviews were conducted with representatives from 20 Canadian NHP companies. Findings show that the rationale for compliance differs for large compared to small and medium-sized enterprises (SMEs). Large firms are motivated to comply with the regulations because of the deterrent fear of negative media coverage, social motivations, ability to comply and maintaining a competitive market advantage. In contrast, SMEs are motivated to comply due to the deterrent fear of legal prosecution and a sense of duty
The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors
BACKGROUND: The use of natural health products, such as vitamins, minerals, and herbs, by Canadians has been increasing with time. As a result of consumer concern about the quality of these products, the Canadian Department of Health created the Natural Health Products (NHP) Regulations. The new Canadian regulations raise questions about whether and how the NHP industry will be able to comply and what impact they will have on market structure. The objectives of this study were to explore who in the interview sample is complying with Canada's new NHP Regulations (i.e., submitted product licensing applications on time); and explore the factors that affect regulatory compliance. METHODS: Twenty key informant interviews were conducted with employees of the NHP industry. The structured interviews focused on the level of satisfaction with the Regulations and perceptions of compliance and non-compliance. Interviews were tape recorded and then transcribed verbatim. Data were independently coded, using qualitative content analysis. Team meetings were held after every three to four interviews to discuss emerging themes. RESULTS: The major finding of this study is that most (17 out of 20) companies interviewed were beginning to comply with the new regulatory regime. The factors that contribute to likelihood of regulatory compliance were: perceptions and knowledge of the regulations and business size. CONCLUSION: The Canadian case can be instructive for other countries seeking to implement regulatory standards for natural health products. An unintended consequence of the Canadian NHP regulations may be the exit of smaller firms, leading to industry consolidation
Human resource management in the Georgian National Immunization Program: a baseline assessment
Background: Georgia's health care system underwent dramatic reform after gaining
independence in 1991. The decentralization of the health care system was one of the core elements
of health care reform but reports suggest that human resource management issues were
overlooked. The Georgian national immunization program was affected by these reforms and is not
functioning at optimum levels. This paper describes the state of human resource management
practices within the Georgian national immunization program in late 2004.
Methods: Thirty districts were selected for the study. Within these districts, 392 providers and
thirty immunization managers participated in the study. Survey questionnaires were administered
through face-to-face interviews to immunization managers and a mail survey was administered to
immunization providers. Qualitative data collection involved four focus groups. Analysis of variance
(ANOVA) and Chi-square tests were used to test for differences between groups for continuous
and categorical variables. Content analysis identified main themes within the focus groups.
Results: Weak administrative links exist between the Centres of Public Health (CPH) and Primary
Health Care (PHC) health facilities. There is a lack of clear management guidelines and only 49.6%
of all health providers had written job descriptions. A common concern among all respondents was
the extremely inadequate salary. Managers cited lack of authority and poor knowledge and skills in
human resource management. Lack of resources and infrastructure were identified as major
barriers to improving immunization.
Conclusion: Our study found that the National Immunization Program in Georgia was
characterized by weak organizational structure and processes and a lack of knowledge and skills in
management and supervision, especially at peripheral levels. The development of the skills and
processes of a well-managed workforce may help improve immunization rates, facilitate successful
implementation of remaining health care reforms and is an overall, wise investment. However,
reforms at strategic policy levels and across sectors will be necessary to address the systemic
financial and health system constraints impeding the performance of the immunization program and
the health care system as a whole
A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue.
Group-2 innate lymphoid cells (ILC2), type-2 cytokines, and eosinophils have all been implicated in sustaining adipose tissue homeostasis. However, the interplay between the stroma and adipose-resident immune cells is less well understood. We identify that white adipose tissue-resident multipotent stromal cells (WAT-MSCs) can act as a reservoir for IL-33, especially after cell stress, but also provide additional signals for sustaining ILC2. Indeed, we demonstrate that WAT-MSCs also support ICAM-1-mediated proliferation and activation of LFA-1-expressing ILC2s. Consequently, ILC2-derived IL-4 and IL-13 feed back to induce eotaxin secretion from WAT-MSCs, supporting eosinophil recruitment. Thus, MSCs provide a niche for multifaceted dialogue with ILC2 to sustain a type-2 immune environment in WAT
Finishing the euchromatic sequence of the human genome
The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
Effectiveness of supportive supervision in improving the performance of national immunization program in Georgia : final technical report
AIDS Policy and Pharmaceutical Patents: Brazil's Strategy to Safeguard Public Health
Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the Brazilian pharmaceutical sector, their public health system and the Brazilian AIDS policy, this paper examines the Brazilian strategy vis-à-vis the international pharmaceutical manufacturers to explore why their tactics were successful and the potential for wider application by other developing countries. Copyright Blackwell Publishing Ltd 2005.